GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
2026: The Promise of Synthetic Biology
2022-08-11
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
10 Precision Oncology Companies to Look Out for
2021-05-27
10 Top Gene Therapy Companies in 2021
2021-03-26
How Does China Tackle the Issue of Patent Protection? A Deepdive into China’s Patent Trends
2021-03-19
Mainstream Generic Drugs Become Stumbling Blocks for Drug Innovation: A Deepdive into China’s Patent Trends
2021-03-17
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
1 2
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!